Patent · US Expired

Cloning of the biosynthetic pathway for chlortetracycline and tetracycline formation and cosmids useful therein

US5866410A · kind A · utility

2Cited by
3References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateFeb 2, 1999
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/18
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention describes a purified and isolated nucleic acid molecule which encodes for the biosynthetic pathway of tetracycline, chlortetracycline or an analogue thereof. The invention relates to the isolation and cloning of the nucleic acid molecule in an isolated fragment from Streptomyces aureofaciens and the expression of the biosynthetic gene in a heterologous host such as Streptomyces lividans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.